Nanovision key facts
as of Oct 2026- Developer of radiation imaging catering to medical, industrial, security and other fields.
- Nanovision is valued at approximately $393.6M as of Oct 2026 (last reported valuation).
- It has raised $100.5M; the latest was Later Stage VC in Dec 2025.
- Notable investors include GL Ventures, Legend Capital, InnoVen Capital, SAIC Capital China, Tencent Investment — 10 tracked in total.
- Status: Privately Held (backing).
Nanovision's last reported valuation, Mar 2022. Nothing priced has surfaced since.
- ·Watch Nanovision: the Monday email on marks, rounds and moves
Nanovision funding rounds
No funding rounds for Nanovision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Nanovision valuation
Nanovision's last reported valuation was $394 million in Mar 2022. No priced round, secondary trade or fund mark has surfaced since.
Nanovision investors
10 investors are on record for Nanovision, including GL Ventures, Legend Capital, InnoVen Capital and SAIC Capital China.
About Nanovision
Developer of radiation imaging catering to medical, industrial, security and other fields. The company offers Chinese first self-developed CMOS flat panel detector, thereby providing industries with domestic and international advanced technology support.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2014
- Employees
- 60
- Website
- nanovision.com.cn/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.